Clearmind Medicine

Clearmind Medicine

Pharmaceuticals
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company’s intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

$2.5M

Market Cap • 10/6/2026

2017

(9 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Canada

Canada

Country

Valuation

P/B

0,2

P/S

—

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

30,8

EPS

—

Market Cap

Market Cap

2,5M

EV

-11,7M

EV/Revenue

0

EV/EBITDA

1,3

EV/EBIT

1,3

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-304,8%

Total Yield

-304,8%

Payout

0%

Retained Earnings

-34,7M

Profitability

Gross Margin

—

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

1%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Op. Income 5Y

50,4%

CAGR Net Income 5Y

42,3%

CAGR OCF 5Y

50,4%

Leverage

N.D./EBITDA

1,6

Debt/Equity

0%

Current Ratio

4,3

Quick Ratio

4,3

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium